S. Sahraoui et al., Nasopharyngeal carcinoma in children under 15 years of age: A retrospective review of 65 patients, ANN ONCOL, 10(12), 1999, pp. 1499-1502
Background: Nasopharyngeal carcinoma constitutescomprises up to 5% of prima
ry childhood cancers but literature lacks modern uniformly treated large se
ries.
Patients and methods: A retrospective review was performed of sixty-five pr
eviously untreated patients younger than 16 years of age diagnosed and trea
ted at the Ibn Rochd Centre in Casablanca between 1988 and 1992. Forty-four
percent of them were stage T-3 to T-4 and 66% stage N-2 or N-3. All patien
ts were irradiated. Prior adjuvant chemotherapy was administered in 33 pati
ents. Thirteen patients were lost to follow-up.
Results: Local control was obtained in 85% of the 52 evaluable patients. Th
e five-year overall survival was 42% and disease-free survival 38%. Ten rel
apses occurred at local and/or regional sites. Six patients have distant me
tastases. All 24 patients with relapse or persistent disease died despite s
alvage therapy. Stage, histology and dose of radiation, were statistically
significant prognostic variables. Patients treated with chemotherapy follow
ed by irradiation had a better outcome than those treated with radiation al
one.
Conclusions: Nasopharyngeal carcinoma in children is a rare chemosensitive
tumor. However, conclusive treatment guidelines cannot be drawn from this s
eries and prospective co-operative studies are needed for the development o
f more effective and less toxic therapeutic strategies.